Pharmaron Total Revenue from 2010 to 2024
| 300759 Stock | 26.99 0.53 1.93% |
Total Revenue | First Reported 2019-03-31 | Previous Quarter 2.7 B | Current Value 2.9 B | Quarterly Volatility 794.5 M |
Check Pharmaron Beijing financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaron Beijing's main balance sheet or income statement drivers, such as Tax Provision of 176.8 M, Interest Income of 30.2 M or Interest Expense of 191.3 M, as well as many indicators such as . Pharmaron financial statements analysis is a perfect complement when working with Pharmaron Beijing Valuation or Volatility modules.
Pharmaron | Total Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pharmaron Stock
Pharmaron Beijing financial ratios help investors to determine whether Pharmaron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaron with respect to the benefits of owning Pharmaron Beijing security.